Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Kaiser Permanente
Duke University
Washington University School of Medicine
Arvinas Inc.
ALX Oncology Inc.
University of Colorado, Denver
City of Hope Medical Center
University of Nebraska
Seagen Inc.
Eli Lilly and Company
Novartis
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals